Total medical devices industry cross border deals worth $3.33bn were announced globally for January 2021, with the $880.85m asset transaction with Novasep Holding being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 33.1% over the previous month of $4.98bn and a rise of 25.2% when compared with the last 12-month average of $2.66bn.
In terms of number of cross border deals, the sector saw a drop of 7.69% with 36 deals in January 2021 when compared to the last 12-month average of 39 deals.
In value terms, Europe led the activity with cross border deals worth $2.06bn in January 2021.
Medical Devices industry cross border deals in January 2021: Top deals
The top five cross border deals accounted for 81.4% of the overall value during January 2021.
The combined value of the top five cross border deals stood at $2.71bn, against the overall value of $3.33bn recorded for the month.
The top five medical devices industry cross border deals of January 2021 tracked by GlobalData were:
1) Thermo Fisher Scientific’s $880.85m asset transaction with Novasep Holding